Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) in predictive toxicology market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Artificial Intelligence (AI) In Predictive Toxicology Market’s size between 2026 and 2030?
The artificial intelligence (ai) in predictive toxicology market has seen significant expansion in recent years. This market is expected to increase from $0.64 billion in 2025 to $0.83 billion in 2026, achieving a compound annual growth rate (CAGR) of 29.3%. The historical growth of the market can be linked to factors such as an escalating demand for safer chemicals, a rise in pharmaceutical research and development efforts, mounting regulatory pressure regarding chemical safety, the initial embrace of computational toxicology, and innovations in bioinformatics tools.
The artificial intelligence (ai) in predictive toxicology market is projected for substantial expansion over the coming years, reaching $2.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 28.9%. This anticipated growth during the forecast period is fueled by factors such as the increasing embrace of AI-powered predictive models, the broadening scope of cloud-based toxicology platforms, the incorporation of genomics and chemical data, enhanced collaboration between pharmaceutical and biotechnology firms, and a growing need for swift chemical safety assessments. Key developments expected within this timeframe involve the synthesis of multi-omics data for predicting toxicity, the development of in silico models for drug toxicity, advanced high-throughput toxicological screening, AI-led chemical prioritization, and efficient cloud-based toxicology data management solutions.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14253&type=smp
Which Drivers Are Shaping Strategic Decisions In The Artificial Intelligence (AI) In Predictive Toxicology Market?
The growing necessity for streamlined and morally sound drug discovery methodologies is expected to stimulate the expansion of the artificial intelligence (AI) in predictive toxicology market. Drug discovery is a complex and evolving endeavor, encompassing the methodical exploration, synthesis, and evaluation of chemical compounds to uncover potential therapeutic agents that alleviate diseases and enhance overall well-being. Efficient and ethical drug discovery processes involve utilizing advanced technologies and prioritizing responsible research practices for developing new therapeutic agents. The impetus for efficient and ethical drug discovery processes stems from the increasing occurrence of chronic diseases, the rising inclination towards personalized medicine, and a greater prevalence of age-related diseases. Artificial intelligence (AI) in predictive toxicology improves drug discovery by proficiently examining vast datasets to forecast potential toxicological results, thus expediting drug development while ensuring ethical guidelines are met. For instance, in 2023, the UK government’s net spending on research and development (R&D) climbed to £17.4 ($22.1 billion) billion, an increase from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% rise, according to the Office for National Statistics. Therefore, the escalating requirement for efficient and ethical drug discovery processes is propelling the growth of the artificial intelligence (AI) in predictive toxicology market.
What Segment Classifications Make Up The Artificial Intelligence (AI) In Predictive Toxicology Market?
The artificial intelligence (ai) in predictive toxicology market covered in this report is segmented –
1) By Component: Solution, Services
2) By Technology: Machine Learning, Other Technologies
3) By Toxicity Endpoints: Genotoxicity, Hepatotoxicity, Neurotoxicity, Cardiotoxicity, Other Toxicity Endpoints
4) By End User: Pharmaceutical And Biotechnology Companies, Chemical And Cosmetics, Contract Research Organizations, Other End Users
Subsegments:
1) By Solution: Software Platforms, Data Analysis Tools, Predictive Modeling Solutions, Database And Information Systems
2) By Services: Consulting Services, Training And Support Services, Data Management And Integration Services, Research And Development Services
What Trends Are Projected To Support The Growth Of The Artificial Intelligence (AI) In Predictive Toxicology Market?
Leading companies in the artificial intelligence (AI) predictive toxicology market are adopting strategic collaboration approaches to enhance their market presence and drive innovation. These partnerships aim to utilize AI and machine learning techniques to improve the prediction and assessment of the toxicity of chemical compounds and pharmaceuticals. For instance, in January 2024, SyntheticGestalt, a UK-based AI research and development company specializing in AI drug discovery solutions, teamed up with Enamine, a Ukraine-based provider of chemical building blocks, screening compounds, and integrated drug discovery services. Their collaboration is focused on developing a set of AI models to facilitate the generation of synthetically accessible biologically active compounds, optimizing their physicochemical and ADME or Tox (Absorption, Distribution, Metabolism, and Excretion or Toxicity) properties. These models will be applied in SyntheticGestalt’s compound discovery efforts, serving both academic users and pharmaceutical companies through their services. Enamine has made its extensive Enamine REAL database, containing 38 billion molecules, available for access. SyntheticGestalt will integrate this database into its Drug Discovery Service, leveraging proprietary AI models to predict the physicochemical and ADME or Tox properties of compounds. The service is designed to promptly suggest improved alternative compounds for those with identified issues.
Which Key Market Players Are Investing In Expansion And Innovation Within The Artificial Intelligence (AI) In Predictive Toxicology Market?
Major companies operating in the artificial intelligence (ai) in predictive toxicology market are Certara Inc, Schrödinger Inc, Instem plc, Simulations Plus Inc, Lhasa Limited, Chemaxon Ltd, Algorithme Pharma, Benevolent AI, Berg Health, Biovista Inc, Recursion Pharmaceuticals Inc, Exscientia plc, Insilico Medicine Inc, Celsius Therapeutics Inc, ArisGlobal, Merative L.P., BioTeam Inc, Leadscope Inc, MultiCASE Inc, ACD Labs, Optibrium Ltd, Chemotargets SL, Toxys BV
Access The Complete Report For Deeper Market Insights:
Which Regions Are Poised For Strategic Growth In The Artificial Intelligence (AI) In Predictive Toxicology Market?
North America was the largest region in the artificial intelligence (AI) in predictive toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in predictive toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Artificial Intelligence (AI) In Predictive Toxicology Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=14253&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Predictive Toxicology Market 2026, By The Business Research Company
Artificial Intelligence Ai In Predictive Toxicology Market Report 2026
Artificial Intelligence In Drug Discovery Market Report 2026
Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model